Back to MW MARSHALL WACE, LLP

CABACABA
Showing 8 of 18 quarters

Position history for MWMARSHALL WACE, LLP's holdings in CABALETTA BIO INC

MARSHALL WACE, LLP holds 1.6M shares of CABA (CABALETTA BIO INC), worth $4.9M as of 2026-Q2. The position was decreased (-28.2% shares). CABA represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$4.9M

Current Shares

1.6M

Total Value Change

+$3.5M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.6M
-28.2%
$4.9M0.0%$3.11
0
2026-Q1
Increased
2.2M
+127.3%
$5.9M0.0%$3.25
44
2025-Q4
Decreased
959,076
-27.7%
$2.1M0.0%$2.15
0
2025-Q3
Increased
1.3M
+594.4%
$3.1M0.0%$2.38
43
2025-Q2
Increased
190,957
+470.7%
$290,2550.0%$1.57
38
2025-Q1
Decreased
33,460
-82.7%
$46,5090.0%$1.55
0
2024-Q4
Decreased
193,225
-31.9%
$438,6220.0%$2.24
0
2024-Q3
Decreased
283,806
-14.1%
$1.3M0.0%$4.26
0

Other major holders of CABA: BlackRock Finance, Inc., FRED ALGER MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used